SCM
NDRM

Segantii Capital Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Segantii Capital Management’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-152,676
Closed -$5.94M – 69
2017
Q3 		$5.94M Buy
+152,676
New +$5.62M 2.32% 15

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Segantii Capital Management's NDRM Position: Q4 2017 in Review

Segantii Capital Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 152,676 shares — an estimated $5.94M sold.

Segantii Capital Management first reported a position in NDRM in Q3 2017 and held it in 1 quarter. The position peaked at $5.94M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Segantii Capital Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Segantii Capital Management sold 152,676 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $5.94M.
  • Segantii Capital Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2017 and held it in 1 quarter.
  • Segantii Capital Management's NeuroDerm Ltd. Ordinary Shares position peaked at $5.94M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Segantii Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.